Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
Yang MW, Fu XL, Jiang YS, Chen XJ, Tao LY, Yang JY, Huo YM, Liu W, Zhang JF, Liu PF, Liu Q, Hua R, Zhang ZG, Sun YW, Liu DJ.
Yang MW, et al.
World J Gastroenterol. 2019 Apr 14;25(14):1684-1696. doi: 10.3748/wjg.v25.i14.1684.
World J Gastroenterol. 2019.
PMID: 31011254
Free PMC article.